Barry D. Quart, Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 100,000 shares at $39.05 ($3.9M) on 2018-06-21, disclosed to the SEC on 2018-06-22.
Open-market sale of $3.9M HRTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.05 | 50,000 | $2.0M | 50.0% |
| 2 | $39.05 | 50,000 | $2.0M | 50.0% |
| Total | $39.05 avg | 100,000 | $3.9M | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |